← Eichor
Condition: Alnd Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Alnd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergo
NA · 54 location(s) · University Hospital, Basel, Switzerland · NCT07140172
Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT07546695
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
Phase N/A · 14 location(s) · European Institute of Oncology · NCT07278726
Omission of ALND in Breast Cancer Patients With Axillary pCR
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05939830
Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)
NA · 1 location(s) · University of Cincinnati · NCT07528638
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With B
Phase 3 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06144164
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
NA · 60 location(s) · Hospital Universitari de Bellvitge · NCT04889924
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.